Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar 9:11:3.
doi: 10.1186/1472-6939-11-3.

Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa

Nicole Mamotte  1 , Douglas Wassenaar, Jennifer Koen, Zaynab Essack
Affiliations

Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa

Nicole Mamotte et al. BMC Med Ethics. .

Abstract

Background: Africa continues to bear a disproportionate share of the global HIV/AIDS, tuberculosis (TB) and malaria burden. The development and distribution of safe, effective and affordable vaccines is critical to reduce these epidemics. However, conducting HIV/AIDS, TB, and/or malaria vaccine trials simultaneously in developing countries, or in populations affected by all three diseases, is likely to result in numerous ethical challenges.

Methods: In order to explore convergent ethical issues in HIV/AIDS, TB and malaria vaccine trials in Africa, the Ethics, Law and Human Rights Collaborating Centre of the WHO/UNAIDS African AIDS Vaccine Programme hosted a consultation on the Convergent Ethical Issues in HIV/AIDS, TB and Malaria Vaccine Trials in Africa in Durban, South Africa on the 10-11 February 2009.

Results: Key cross cutting ethical issues were prioritized during the consultation as community engagement; ancillary care obligations; care and treatment; informed consent; and resource sharing.

Conclusion: The consultation revealed that while there have been few attempts to find convergence on ethical issues between HIV/AIDS, TB and malaria vaccine trial fields to date, there is much common ground and scope for convergence work between stakeholders in the three fields.

PubMed Disclaimer

References

    1. UNAIDS. 2008 Report on the global AIDS epidemic. Geneva: UNAIDS; 2008.
    1. WHO. Global tuberculosis control - epidemiology, strategy, financing. Geneva: WHO; 2009.
    1. von Reyna CF, Mteib L, Arbeitc RD, Waddella R, Coled B, Mackenziee T, Mateeb M, Bakarib M, Tvarohaa S, Adamsa LV, Horsburghf CR, Pallangyob K. the DarDar Study Group. Prevention of tuberculosis in Bacille Calmette--Gue'rin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine. AIDS. 2010;11:000–000. - PMC - PubMed
    1. WHO. World Malaria Report 2008. Geneva: WHO; 2008.
    1. WHO. The three I's: Intensified case finding (ICF), isoniazid preventive therapy (IPT) and TB infection control (IC) for people living with HIV. Geneva: WHO; 2008.

MeSH terms